Rush University Medical Center
S

Reaching for Resmitirom or Sticking with Semaglutide?

By Rush University Medical Center FEATURING Sujit Janardhan
By Rush University Medical Center FEATURING Sujit Janardhan
2 views
February 23, 2024
0 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
18:43
ASPC 2019 Congress on CVD Prevention

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

Feat. R. DeFronzo
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

18:46
Houston Methodist Hospital

MAFLD: What Is It?

Feat. D. Victor
27:24
Cardiometabolic Health Congress (CMHC)

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Feat. L. Sloan
23:35
Canadian Collaborative Research Network

Is Obesity Management the Next Frontier?

Feat. A. Michael Lincoff
26:49
Diana Isaacs

Tirzepatide Updates

20:24
Diana Isaacs

Tirzepatide for Type 2 Diabetes

63:54
Baystate Health

Ozempic, Zepbound, and More: Behavioral Interventions & Weight L…

Feat. M. Gortakowski, K. Jobbins
06:31
Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

05:08
Susan Brian

The Differences Between the Products of GLP1's and GLP/GIPs

36:34
Scripps Health

GLP-1 Hysteria

Feat. S. Harris
43:23
MedNews Week

Best Practices In Managing NAFLD / NASH

Feat. D. Bernstein
13:33
Dr. Sharmila Ghimire

Daily Oral GLP-1 Receptor Agonist Orforglipron for Adults with Obesi…

Feat. D. Ghimire
49:21
McMaster University Department of Medicine

Semaglutide: Where Are We Now and Where Are We Going?

Feat. S. Boushahri, D. Lazzam, K. MacEachern
05:40
Susan Brian

An Introduction to Tirzepatide for Weightloss

10:02
Susan Brian

Tirzepatide and Type 1 Diabetes

07:41
Susan Brian

Weightloss in Menopause